Morgan Stanley analyst James Faucette lowered the firm's price target on SS&C to $78 from $86 and keeps an Equal Weight rating on the shares. While "encouraged by organic growth stability," which seems supported by broad-based strength in both pipelines as well as renewal opportunities with longer duration, a debate will continue on AI and tokenization, the analyst tells investors in a post-Q1 note.
